Androgenetic Alopecia
📧 Sign up to get email alerts when something new happens for Androgenetic Alopecia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Evaluation of the Dietary Supplement Efficacy Against Hair Loss in Subjects Suffering From Hair Loss [NA]
Clinical trial update announcing the completion of a study evaluating a dietary supplement for hair loss in people with androgenetic alopeci…
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Effectiveness of Apheresis Platelet-Rich Plasma Injection for Androgenic Alopecia [Phase 2]
Phase 2 trial evaluating the effectiveness of apheresis platelet-rich plasma injections for androgenetic alopecia has completed.
-
FDA approval · 2026-01-14FDA Approved: MENS ROGAINE EXTRA STRENGTH UNSCENTED — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for Men’s Rogaine Extra Strength Unscented (minoxidil) by Kenvue Brands LLC, updating labeling to re…
-
FDA approval · 2026-01-14FDA Approved: WOMENS ROGAINE UNSCENTED — Supplemental Application (Kenvue Brands LLC)
The FDA approved a supplemental application for Women's Rogaine Unscented, a minoxidil topical product from Kenvue Brands LLC.
-
FDA approval · 2026-01-14FDA Approved: WOMENS ROGAINE UNSCENTED — Supplemental Application (Kenvue Brands LLC)
FDA records show a supplemental application for Women's Rogaine Unscented (minoxidil) from Kenvue Brands LLC, with the submission status AP.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: Efficacy and Safety Evaluation of a Nutraceutical Supplement for Hair Growth, Hair Loss and Skin Improvement in Human Volunteers [NA]
A completed human trial evaluated the efficacy and safety of a nutraceutical supplement for hair growth, hair loss, and skin improvement. Th…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of N1087 in Participants With Female Pattern Hair Loss (MINORA-WOMEN) [Phase 3]
Phase 3 study to evaluate the efficacy and safety of N1087 in female pattern hair loss (MINORA-WOMEN); recruitment status is NOT_YET_RECRUIT…
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia [Phase 1, Phase 2]
Clinical trial update for ABS-201 evaluating single and multiple ascending doses in healthy adults with and without androgenetic alopecia; P…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Clinical Evaluation of a Nutraceutical Supplement for Hair Growth, Hair Loss and Skin Improvement in Human Volunteers Versus Placebo [NA]
A clinical trial is evaluating a nutraceutical supplement for hair growth, hair loss, and skin improvement in women with early female patter…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Olistic_2025 for Hair Loss, Hair Growth, and Skin Improvement [NA]
The Olistic_2025 trial for hair loss, hair growth, and skin improvement sponsored by Bionos Biotech S.L. is currently active but not recruit…
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (SCALP2) [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of clascoterone solution for androgenetic alopecia has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Evaluation of the Safety, Tolerability and Pharmacokinetics of AH-001 Following Topical Single and Multiple Ascending Dose Administration [Phase 1]
Phase 1 study evaluating safety, tolerability, and pharmacokinetics of topical AH-001 for androgenetic alopecia; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Safety, Pharmacokinetics and Efficacy of PP405 in Adults With AGA [Phase 2]
Phase 2 trial results for PP405 in adults with androgenetic alopecia, detailing safety, pharmacokinetics, and efficacy.
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: Comparison of Outcomes Between Topical Minoxidil Versus Oral Minoxidil for the Treatment of Androgenetic Alopecia [Phase 3]
A Phase 3 clinical trial compares topical versus oral minoxidil for androgenetic alopecia and is currently not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia [Phase 3]
Phase 3 trial evaluating the efficacy and safety of Finlândia Hair Lotion Association for androgenetic alopecia is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: A Safety and Efficacy Study of a Nutraceutical in Aging Males With Thinning Hair [NA]
A safety and efficacy trial of a nutraceutical for thinning hair in aging males has been terminated.
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: A Study on the Treatment of Androgenetic Alopecia in Young Men With Umbilical Cord Mesenchymal Stem Cell Exosomes [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating umbilical cord mesenchymal stem cell exosomes for androgenetic alopecia in young men; the study is cur…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: A Split-Scalp Study Evaluating the Efficacy and Safety of Fractional Laser Therapy With and Without Exosomes in the Treatment of Androgenetic Alopecia [NA]
This clinical trial update describes a split-scalp study evaluating fractional laser therapy with and without exosomes for androgenetic alop…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA) [Phase 3]
This clinical trial update reports on a Phase 3 study of VDPHL01 for use in females with androgenetic alopecia (AGA). Recruitment is ongoing…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Evaluating the Efficacy of Platelet-rich Plasma Therapy in the Treatment of Androgenic Alopecia [EARLY_Phase 1]
A Phase 1 clinical trial is evaluating the efficacy of platelet-rich plasma therapy for androgenetic alopecia, with status not yet recruitin…
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic Alopecia [Phase 2]
Phase 2 study evaluating the topical agent TDM-105795 for androgenetic alopecia in men has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2025-11-06Clinical Trial Update: Safety and Efficacy of VDPHL01 in Males and Females With AGA [Phase 2]
Phase 2 clinical trial assessing the safety and efficacy of VDPHL01 for androgenetic alopecia in adult males and females; the study is curre…
-
CLINICAL_TRIALS trial_result · 2025-11-06Clinical Trial Update: Efficacy and Safety of VDPHL01 in Males With AGA [Phase 2, Phase 3]
Phase 2/Phase 3 trial update for VDPHL01 in men with androgenetic alopecia (AGA). The study is currently active but not recruiting.
-
CLINICAL_TRIALS withdrawal · 2025-09-12Clinical Trial Update: AGA Biocellular Stem/Stromal Hair Regenerative Study [Phase 1, Phase 2]
The AGA Biocellular Stem/Stromal Hair Regenerative Study (Phase 1/Phase 2) conducted by Healeon Medical Inc. has been withdrawn. The trial r…
-
CLINICAL_TRIALS trial_result · 2025-09-09Clinical Trial Update: An Exploratory Clinical Study to Assess Safety, Efficacy and In-Use Tolerability of Three Different Hair Growth Products in Patients With Mild to Moderate Androgenic Alopecia (Grade I to III) [NA]
An exploratory, completed trial evaluating safety, efficacy, and tolerability of three hair growth products in patients with mild to moderat…